CN Patent

CN109310627B — 福奈妥匹坦的生理平衡注射制剂

Assigned to Helsinn Healthcare SA · Expires 2021-12-14 · 4y expired

What this patent protects

提供了对于安全性和效力来说有效、化学稳定和生理平衡的福奈妥匹坦(fosnetupitant)及其可药用盐的注射剂量和制剂。

USPTO Abstract

提供了对于安全性和效力来说有效、化学稳定和生理平衡的福奈妥匹坦(fosnetupitant)及其可药用盐的注射剂量和制剂。

Drugs covered by this patent

fosnetupitant-chloride-hydrochloride (FOSNETUPITANT CHLORIDE HYDROCHLORIDE)

Patent Metadata

Patent number: CN109310627B
Jurisdiction: CN
Classification: —
Expires: 2021-12-14
Drug substance claim: No
Drug product claim: No
Assignee: Helsinn Healthcare SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.